Detailed Information on Publication Record
2021
COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines’ Side Effects
RIAD, Abanoub, Holger SCHÜNEMANN, Sameh ATTIA, Tina POKLEPOVIĆ PERIČIĆ, Marija Franka ŽULJEVIĆ et. al.Basic information
Original name
COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines’ Side Effects
Authors
RIAD, Abanoub (818 Egypt, guarantor, belonging to the institution), Holger SCHÜNEMANN, Sameh ATTIA, Tina POKLEPOVIĆ PERIČIĆ, Marija Franka ŽULJEVIĆ, Mikk JÜRISSON, Ruth KALDA, Katrin LANG, Sudhakar MORANKAR, Elias Ali YESUF, Mohamed MEKHEMAR, Anthony DANSO-APPIAH, Ahmad SOFI-MAHMUDI, Giordano PÉREZ-GAXIOLA, Arkadiusz DZIEDZIC, João APÓSTOLO, Daniela CARDOSO, Janja MARC, Mayte MORENO-CASBAS, Charles Shey WIYSONGE, Amir QASEEM, Anna GRYSCHEK, Ivana TADIĆ, Mohammad Salman HUSSAIN (356 India, belonging to the institution), Mohammed Ahmed KHAN, Jitka KLUGAROVÁ (203 Czech Republic, belonging to the institution), Andrea POKORNÁ (203 Czech Republic, belonging to the institution), Michal KOŠČÍK (203 Czech Republic, belonging to the institution) and Miloslav KLUGAR (203 Czech Republic, belonging to the institution)
Edition
International Journal of Environmental Research and Public Health, Basel, MDPI, 2021, 1660-4601
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30304 Public and environmental health
Country of publisher
Switzerland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 4.614
RIV identification code
RIV/00216224:14110/21:00122061
Organization unit
Faculty of Medicine
UT WoS
000681945000001
Keywords in English
cohort studies; cross-sectional studies; COVID-19; drug-related side effects and adverse reactions; health personnel; mass vaccination; prevalence
Tags
International impact, Reviewed
Změněno: 12/12/2022 13:40, Mgr. Tereza Miškechová
Abstract
V originále
Background: Coronavirus disease (COVID-19) vaccine-related side effects have a determinant role in the public decision regarding vaccination. Therefore, this study has been designed to actively monitor the safety and effectiveness of COVID-19 vaccines globally. Methods: A multi-country, three-phase study including a cross-sectional survey to test for the short-term side effects of COVID-19 vaccines among target population groups. In the second phase, we will monitor the booster doses’ side effects, while in the third phase, the long-term safety and effectiveness will be investigated. A validated, self-administered questionnaire will be used to collect data from the target population; Results: The study protocol has been registered at ClinicalTrials.gov, with the identifier NCT04834869. Conclusions: CoVaST is the first independent study aiming to monitor the side effects of COVID-19 vaccines following booster doses, and the long-term safety and effectiveness of said vaccines.
Links
MUNI/A/1608/2020, interní kód MU |
| ||
MUNI/IGA/1543/2020, interní kód MU |
|